BIOMAT Database Logo BIOMAT Database Logo

Early signs and course of disease of glutaryl-CoA dehydrogenase deficiency. 1995

G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Department of Pediatrics, University of Marburg, Germany.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D001928 Brain Diseases, Metabolic Acquired or inborn metabolic diseases that produce brain dysfunction or damage. These include primary (i.e., disorders intrinsic to the brain) and secondary (i.e., extracranial) metabolic conditions that adversely affect cerebral function. Central Nervous System Metabolic Disorders,Encephalopathies, Metabolic,Metabolic Disorders, Brain,Acquired Metabolic Diseases, Brain,Acquired Metabolic Diseases, Nervous System,Acquired Metabolic Encephalopathies,Brain Diseases, Metabolic, Acquired,Brain Disorders, Metabolic,Brain Disorders, Metabolic, Acquired,Brain Syndrome, Metabolic,Brain Syndrome, Metabolic, Acquired,CNS Metabolic Disorders,CNS Metabolic Disorders, Acquired,Encephalopathy, Metabolic, Acquired,Metabolic Brain Diseases,Metabolic Brain Diseases, Acquired,Metabolic Brain Syndrome,Metabolic Brain Syndrome, Acquired,Metabolic Brain Syndromes,Metabolic Brain Syndromes, Acquired,Metabolic Diseases, Acquired, Nervous System,Metabolic Disorder, Central Nervous System, Acquired,Metabolic Disorders, CNS,Metabolic Disorders, CNS, Acquired,Metabolic Disorders, Central Nervous System,Metabolic Encephalopathies,Nervous System Acquired Metabolic Diseases,Acquired Metabolic Encephalopathy,Brain Disease, Metabolic,Brain Disorder, Metabolic,Brain Metabolic Disorder,Brain Metabolic Disorders,CNS Metabolic Disorder,Encephalopathies, Acquired Metabolic,Encephalopathy, Acquired Metabolic,Encephalopathy, Metabolic,Metabolic Brain Disease,Metabolic Brain Disorder,Metabolic Brain Disorders,Metabolic Disorder, Brain,Metabolic Disorder, CNS,Metabolic Encephalopathies, Acquired,Metabolic Encephalopathy,Metabolic Encephalopathy, Acquired
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D044925 Oxidoreductases Acting on CH-CH Group Donors A subclass of enzymes which includes all dehydrogenases acting on carbon-carbon bonds. This enzyme group includes all the enzymes that introduce double bonds into substrates by direct dehydrogenation of carbon-carbon single bonds. Oxidoreductases Acting on CH CH Group Donors
D050770 Glutaryl-CoA Dehydrogenase A flavoprotein enzyme that is responsible for the catabolism of LYSINE; HYDROXYLYSINE; and TRYPTOPHAN. It catalyzes the oxidation of GLUTARYL-CoA to crotonoyl-CoA using FAD as a cofactor. Glutaric aciduria type I is an inborn error of metabolism due to the deficiency of glutaryl-CoA dehydrogenase. Glutaryl CoA Dehydrogenase,Glutaryl-Coenzyme A Dehydrogenase,CoA Dehydrogenase, Glutaryl,Dehydrogenase, Glutaryl CoA,Dehydrogenase, Glutaryl-CoA,Dehydrogenase, Glutaryl-Coenzyme A,Glutaryl Coenzyme A Dehydrogenase
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.
June 1996, Neuropediatrics,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Glutaryl-CoA dehydrogenase deficiency.
January 2007, Pediatric research,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Riboflavin-responsive glutaryl CoA dehydrogenase deficiency.
May 2006, Molecular genetics and metabolism,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency.
June 2005, Neurology,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Maintenance treatment of glutaryl-CoA dehydrogenase deficiency.
January 2004, Journal of inherited metabolic disease,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency.
October 2007, Journal of inherited metabolic disease,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Neonatal screening for glutaryl-CoA dehydrogenase deficiency.
January 2004, Journal of inherited metabolic disease,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Emergency treatment in glutaryl-CoA dehydrogenase deficiency.
January 2004, Journal of inherited metabolic disease,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Animal models for glutaryl-CoA dehydrogenase deficiency.
January 2004, Journal of inherited metabolic disease,
G F Hoffmann, and H J Böhles, and A Burlina, and M Duran, and J Herwig, and W Lehnert, and J V Leonard, and A Muntau, and F K Plecko-Starting, and A Superti-Furga
Excitotoxicity and bioenergetics in glutaryl-CoA dehydrogenase deficiency.
January 2004, Journal of inherited metabolic disease,
Copied contents to your clipboard!